Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. The Company’s advanced cross-linking technology makes an entirely new cross-linking procedure possible; Lasik Xtra®, intra-operative accelerated cross-linking following the creation of the flap during Lasik. Today more than 50,000 eyes around the world have been treated with Avedro’s KXL ® System for Accelerated Cross-linking. Outside the US, Avedro has obtained CE Mark for its KXL System and its family of riboflavin products. Learn More
Avedro’s products are not available for sale in the US.